{"nct_id":"NCT01770743","title":"A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels","status":"COMPLETED","status_verified_date":"2024-03","start_date":"2013-01","start_date_type":null,"primary_completion_date":"2014-02","primary_completion_date_type":"ACTUAL","completion_date":"2014-12","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["EBS"]}